Broadly neutralizing antibodies against influenza virus and prospects for universal therapies - Wikidata - thesis-toulmin - TriplyDB

Broadly neutralizing antibodies against influenza virus and prospects for universal therapies

Broadly neutralizing antibodies against influenza virus and prospects for universal therapies

http://www.wikidata.org/entity/Q27010503

about

Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies Matrix-M Adjuvated Seasonal Virosomal Influenza Vaccine Induces Partial Protection in Mice and Ferrets against Avian H5 and H7 Challenge Mechanisms of hemagglutinin targeted influenza virus neutralization Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin A common solution to group 2 influenza virus neutralization Prevention of influenza by targeting host receptors using engineered proteins A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen Using Clinical Trial Simulators to Analyse the Sources of Variance in Clinical Trials of Novel Therapies for Acute Viral Infections.A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response Large-scale analysis of B-cell epitopes on influenza virus hemagglutinin - implications for cross-reactivity of neutralizing antibodies.Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness.Generation of human neutralizing monoclonal antibodies against the 2009 pandemic H1N1 virus from peripheral blood memory B lymphocytes Adjuvants and immunization strategies to induce influenza virus hemagglutinin stalk antibodies How Can Viral Dynamics Models Inform Endpoint Measures in Clinical Trials of Therapies for Acute Viral Infections?Understanding the within-host dynamics of influenza A virus: from theory to clinical implications Continuing challenges in influenza.In silico structural homology modelling and docking for assessment of pandemic potential of a novel H7N9 influenza virus and its ability to be neutralized by existing anti-hemagglutinin antibodies.Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells.Cross-Neutralising Nanobodies Bind to a Conserved Pocket in the Hemagglutinin Stem Region Identified Using Yeast Display and Deep Mutational Scanning.Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination Workshop report: Immunoassay standardisation for "universal" influenza vaccines.SnapShot: broadly neutralizing antibodies.Generation of monoclonal pan-hemagglutinin antibodies for the quantification of multiple strains of influenza.High-throughput identification of loss-of-function mutations for anti-interferon activity in the influenza A virus NS segment.Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine.A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms An Anti-Influenza Virus Antibody Inhibits Viral Infection by Reducing Nucleus Entry of Influenza Nucleoprotein.In Silico Identification of Highly Conserved Epitopes of Influenza A H1N1, H2N2, H3N2, and H5N1 with Diagnostic and Vaccination Potential Designing tomorrow's vaccines.Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein.Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA.Influenza a virus entry: implications in virulence and future therapeutics.Vaccines based on structure-based design provide protection against infectious diseases.Broadly neutralizing antibodies and the promise of universal vaccines: where are we now?

P2860

Q26744622-1D81C198-1B85-4DF5-A837-6717035A1202 Q26823492-34B06EBB-2BD4-4664-A2B2-38994DDD1CA1 Q27300233-AD2E484B-E94F-4B98-8EE5-4A0F5447D16E Q27302234-09BA42D7-BDD5-4DFB-BBAE-86E43CE926AE Q27673861-91D67575-0F9A-46FC-94EA-60EDB9DEFBDB Q27676298-108BA96B-FECF-4CD4-B976-D9035DAFBA8E Q27680873-FC101503-60C4-42F0-B6DD-48CB4CD2445F Q27683378-DE397EC5-6294-4D4E-A693-40B430F8E901 Q27701889-362B7C44-9596-40B8-B963-AFC5D52A80A1 Q28552030-E0745E61-F5D7-40F5-8C5C-7FE331CD52DD Q28553101-1DAD4E8C-F815-4ECB-89CE-98045937093E Q30217235-DBD6D62E-315A-4D8C-A928-D2E7E4E8A05C Q30223058-B2D17E4D-B6D6-432E-B846-9261BC14655E Q30352589-0A6CC0BA-860A-4CD4-9280-30825EE03964 Q30355516-5BF44E4C-B653-4A33-801F-AA225B5D9018 Q30357603-32363ADE-405C-4A00-ABFF-BBB12B2B4E72 Q30357678-B517C706-A9F8-4DB9-8E76-98E5B62081E0 Q30363190-3EEA6304-3F3B-4624-8AF5-717C8CF84908 Q30364943-2A95DCE0-0B28-40A4-8085-55952D63D6B2 Q30370793-B9C07295-6D6C-4D41-83FA-6F5FBE9B7A21 Q30382787-6B516D20-3D1C-4AA1-8998-11DD23F52D1C Q30394097-3F91325F-1247-4B5A-8FBC-BEF350CB21EA Q30427591-2BC5730C-8C1B-424C-B63F-21C948C51B3E Q30427950-AB09E142-1D56-4010-A531-685CA394D7A1 Q30429248-318BF485-3827-4181-AFF4-2D9319D7A926 Q33619871-6D80A686-4813-4335-BC03-AEBBC9AB2C77 Q33804585-17D2064D-C57D-42DE-87D8-626EE7881126 Q33853581-C6C45CA3-C8C7-48BA-9F5B-4F1B33C5B281 Q34059442-0753913B-93FA-498D-A0AA-0739963169EC Q34520430-A2ED80C9-0BFF-4BDE-9376-3CEBF0D78929 Q35488279-05F7D772-44FD-4B26-9833-0FE49DB1E2D6 Q35825796-2AA3E700-1D2C-4623-A769-D5E1985F5B89 Q35982621-D1707E28-0A2E-4853-82CD-1EF6EA5A6188 Q36730618-3B6EC1E8-56C1-472F-B9DC-FC711266098B Q36911722-BE51E224-C51C-41B9-B619-F6D4BA02E0CA Q36978206-FEB2828C-8C2D-408F-9407-63EDF456AAE1 Q38050485-B633C6DE-741D-4C58-A21B-52B06EF85571 Q38077952-F026BFD9-3C10-4501-9C60-0234A9E858F1 Q38148782-67242995-10FE-4626-9651-A8455FB13BD6 Q38171571-FB80FF85-4EE6-41D7-8956-D2E9E3E2D024

P2860

Broadly neutralizing antibodies against influenza virus and prospects for universal therapies

http://www.wikidata.org/entity/Q27010503

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Broadly neutralizing antibodie ...... spects for universal therapies

@ast

Broadly neutralizing antibodie ...... spects for universal therapies

@en

Broadly neutralizing antibodie ...... spects for universal therapies

@nl

type

label

Broadly neutralizing antibodie ...... spects for universal therapies

@ast

Broadly neutralizing antibodie ...... spects for universal therapies

@en

Broadly neutralizing antibodie ...... spects for universal therapies

@nl

prefLabel

Broadly neutralizing antibodie ...... spects for universal therapies

@ast

Broadly neutralizing antibodie ...... spects for universal therapies

@en

Broadly neutralizing antibodie ...... spects for universal therapies

@nl

P1433

Q27010503-11549D9A-FC16-4137-998B-586D3A566A01

P1476

Q27010503-CB24B3C4-F493-4679-A6E0-789B2A1C501C

P2093

Q27010503-623AD461-8542-4F70-9B90-D7A4D3365463

P2860

Q27010503-0418A42A-C071-4AA5-A913-EFD77314DE83

Q27010503-10038D4B-44F6-4146-AAE8-5B6B4B121504

Q27010503-1C59E975-861C-4393-8ADD-B95694FE665D

Q27010503-20589F14-5753-4DA5-9E1E-C410EA8E8BDE

Q27010503-2D4F3073-1540-4FC9-A49D-BC7E9D97CE67

Q27010503-2E950F36-99E3-4FBC-A843-7A3FFC64A33F

Q27010503-3727C4FC-68FF-4803-ACBC-4D0F62115F41

Q27010503-4B60B1DB-6A26-4B34-9BCF-5E433F768691

Q27010503-5B2CF8CF-B60D-4BB6-857C-FE323B9DAF2A

Q27010503-61A89416-B76F-4F06-95C1-59DA54C16146

P304

Q27010503-4FD3B5B7-AFE6-4DFF-B39F-FB541E0F842E

P31

Q27010503-8E4A01B4-D126-4C66-AA7C-73E4EC49180C

P3181

Q27010503-302135DA-52E1-44E6-B32D-2CA0B366C74A

P356

Q27010503-144C3BD5-63B6-4E22-B579-9A3307A6FEFC

P407

Q27010503-5262579C-9FF6-4E1D-B205-7E41B6560278

P433

Q27010503-BB107FA4-FA75-4AFE-A79E-84729553E405

P478

Q27010503-397D4265-7667-4E0F-BE9C-B34A3F9FEFD1

P50

Q27010503-A2777A15-857D-4D8A-9149-F1D252F2D406

P577

Q27010503-99281438-0B60-44ED-A493-62DEFA971081

P5875

Q27010503-FE933F49-3ECF-4A5B-8E89-DBD41BE19FB6

P698

Q27010503-4E43EF76-278B-4C67-95E2-42E55EF55688

P921

Q27010503-36F4B977-5D65-4053-9ED6-AD959D5D23AD

Q27010503-D71E7D66-40A0-4C90-B64B-766F9583C30E

P932

Q27010503-FC04F643-1BBE-4D1B-8A29-00C41693CC0A

P3181

P356

J.COVIRO.2012.02.005

P1433

Current opinion in virology

P1476

Broadly neutralizing antibodie ...... spects for universal therapies

@en

P2093

Damian C Ekiert

http://www.w3.org/2001/XMLSchema#string

P2860

Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes

A highly conserved neutralizing epitope on group 2 influenza A viruses

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Antibody recognition of a highly conserved influenza virus epitope

Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein

Computational Design of Proteins Targeting the Conserved Stem Region of Influenza Hemagglutinin

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin

P304

134-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

321325

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.COVIRO.2012.02.005

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Ian Andrew Wilson

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223964119

http://www.w3.org/2001/XMLSchema#string

P698

22482710

http://www.w3.org/2001/XMLSchema#string

P921

P932

3368890

http://www.w3.org/2001/XMLSchema#string